Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice

Journal of General Virology

Volumn 81, Issue 3, 2000, Pages 737-742

  Solorzano, Alicia ^a,c   Zheng, Hongyong ^a   Fodor, Ervin ^b   Brownlee, George G ^b   Palese, Peter ^a   García Sastre, Adolfo ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; LIVE VACCINE; MESSENGER RNA; RIBONUCLEOPROTEIN; VIRUS SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC TRANSFECTION; INFLUENZA VIRUS A; LUNG; MOUSE; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PROVOCATION TEST; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALIA; INFLUENZA A VIRUS; INFLUENZA A VIRUS (A/WSN/33); INFLUENZA VIRUS; RNA VIRUSES;

EID: 0033952995     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-3-737     Document Type: Article

References (46)

1. Baker, A. T., Varghese, J. N., Laver, W. G., Air, G. M. & Colman, P. M. (1987). Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus. Proteins 2, 111-117.
2. Bilsel, P. & Kawaoka, Y. (1998). New approaches to vaccination. In Textbook of Influenza, pp. 422-434. Edited by K. G. Nicholson, R. G. Webster & A. J. Hay. Oxford: Blackwell Science.
3. Bot, A., Antohi, S., Bot, S., García-Sastre, A. & Bona, C. (1997). Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. International Immunology 9, 1641-1650.
4. Both, G. W., Sleigh, M. J., Cox, N. J. & Kendal, A. P. (1983). Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. Journal of Virology 48, 52-60.
5. Burnet, F. M. & Stone, J. D. (1947). The receptor-destroying enzyme of V. cholerae. Australian Journal of Experimental Medical Sciences 25, 227-233.
6. Calfee, D.P. & Hayden, F. G. (1998). New approaches to influenza chemotherapy. Neuraminidase inhibitors. Drugs 56, 537-553.
7. Castrucci, M. R., Bilsel, P. & Kawaoka, Y. (1992). Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. Journal of Virology 66, 4647-4653.
8. Enami, M., Luytjes, W., Krystal, M. & Palese, P. (1990). Introduction of site-specific mutations into the genome of influenza virus. Proceedings of the National Academy of Sciences, USA 87, 3802-3805.
9. Fleming, D. M. (1999). Treating influenza with zanamivir. Lancet 353, 668-669.
10. Fodor, E., Pritlove, D. C. & Brownlee, G. G. (1995). Characterization of the RNA-fork model of virion RNA in the initiation of transcription in influenza A virus. Journal of Virology 69, 4012-4019.
11. Fodor, E., Palese, P., Brownlee, G.G. & García-Sastre, A. (1998). Attenuation of influenza A virus mRNA levels by promoter mutations. Journal of Virology 72, 6283-6290.
12. Fodor, E., Devenish, L, Engelhardt, O. G., Palese, P., Brownlee, G. G. & García-Sastre, A. (1999). Rescue of influenza A virus from recombinant DNA. Journal of Virology 73, 9679-9682.
13. García-Sastre, A. (1998). Negative-strand RNA viruses: applications to biotechnology. Trends in Biotechnology 16, 230-235.
14. García-Sastre, A., Villar, E., Hannoun, C. & Cabezas, J. A. (1990). Sialidase activity in rimantadine-resistant and -sensitive influenza A viruses. Enzyme 43, 207-211.
15. Gutierrez, A. L., Denova-Ocampo, M., Racaniello, V. R. & del Angel, R. M. (1997). Attenuating mutations in the poliovirus 5′ untranslated region alter its interaction with polypyrimidine tract-binding protein. Journal of Virology 71, 3826-3833.
16. Haller, A. A., Stewart, S. R. & Semler, B. L. (1996). Attenuation stem-loop lesions in the 5′ noncoding region of poliovirus RNA: neuronal cell-specific translation defects. Journal of Virology 70, 1467-1474.
17. Hayden, F. G., Osterhaus, A. D., Treanor, J. J., Fleming, D. M., Aoki, F. Y., Nicholson, K. G., Bohnen, A. M., Hirst, H. M., Keene, O. & Wightman, K. (1997). Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. New England Journal of Medicine 337, 874-880.
18. Hsu, M. T., Parvin, J. D., Gupta, S., Krystal, M. & Palese, P. (1987). Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proceedings of the National Academy of Sciences, USA 84, 8140-8144.
19. Kawaoka, Y., Krauss, S. & Webster, R. G. (1989). Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. Journal of Virology 63, 4603-4608.
20. Kim, H. J., Fodor, E., Brownlee, G. G. & Seong, B. L. (1997). Mutational analysis of the RNA-fork model of the influenza A virus vRNA promoter in vivo. Journal of General Virology 78, 353-357.
21. Lamb, R. A. & Krug, R. M. (1996). Orthomyxoviridae. The viruses and their replication. In Fields Virology, 2nd edn, pp. 1353-1395. Edited by B. N. Fields, D. M Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
22. La Monica, N. & Racaniello, V. R. (1989). Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. Journal of Virology 63, 2357-2360.
23. Li, S., Liu, C, Klimov, A., Subbarao, K., Perdue, M. L., Mo, D., Ji, Y., Woods, L., Hietala, S. & Bryant, M. (1999). Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. Journal of Infectious Diseases 179, 1132-1138.
24. Liu, C. & Air, G. M. (1993). Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes. Virology 194, 403-407.
25. Liu, C., Eichelberger, M. C., Compans, R. W. & Air, G. M. (1995). Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. Journal of Virology 69, 1099-1106.
26. Luo, G. X., Luytjes, W., Enami, M. & Palese, P. (1991). The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. Journal of Virology 65, 2861-2867.
27. Luo, G., Bergmann, M., García-Sastre, A. & Palese, P. (1992). Mechanism of attenuation of a chimeric influenza A/B transfectant virus. Journal of Virology 66, 4679-4685.
28. Luo, G., Chung, J. & Palese, P. (1993). Alterations of the stalk of the influenza virus neuraminidase: deletions and insertions. Virus Research 29, 141-153.
29. Maassab, H. F., LaMontagne, J. R. & DeBorde, D. C. (1998). Live influenza virus vaccines. In Vaccines, pp. 435-457, Edited by S. A. Plotkin & E. A. Mortimer. Philadelphia: Saunders.
30. Murphy, B. R. & Webster, R. G. (1996). Orthomyxoviruses. In Fields Virology, pp. 1397-1445. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
31. Muster, T., Subbarao, E. K., Enami, M., Murphy, B. R. & Palese, P. (1991). An influenza A virus containing influenza B virus 5′ and 3′ noncoding regions on the neuraminidase gene is attenuated in mice. Proceedings of the National Academy of Sciences, USA 88, 5177-5181.
32. Neumann, G., Watanabe, T., Ito, H., Watanabe, S., Goto, H., Gao, P., Hughes, M., Perez, D. R., Donis, R., Hoffmann, E., Hobom, G. & Kawaoka, Y. (1999). Generation of influenza A viruses entirely from cloned cDNAs. Proceedings of the National Academy of Sciences, USA 96, 9345-9350.
33. Palese, P. & Compans, R. W. (1976). Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. Journal of General Virology 33, 159-163.
34. Palese, P., Schulman, J. L., Bodo, G. & Meindl, P. (1974). Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA). Virology 59, 490-498.
35. Palese, P., Muster, T., Zheng, H., O'Neill, R. & García-Sastre, A. (1999). Learning from our foes: a novel vaccine concept for influenza virus. Archives of Virology 15, 1-8.
36. Parkin, N.T., Chiu, P. & Coelingh, K. (1997). Genetically engineered live attenuated influenza A virus vaccine candidates. Journal of Virology 71, 2772-2778.
37. Pleschka, S., Jaskunas, R., Engelhardt, O. G., Zürcher, T., Palese, P. & García-Sastre, A. (1996). A plasmid-based reverse genetics system for influenza A virus. Journal of Virology 70, 4188-4192.
38. Pritlove, D. C., Fodor, E., Seong, B. L. & Brownlee, G. G. (1995). In vitro transcription and polymerase binding studies of the termini of influenza A virus cRNA: evidence for a cRNA panhandle. Journal of General Virology 76, 2205-2213.
39. Scholtissek, C., Rohde, W., Von Hoyningen, V. & Rott, R. (1978). On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87, 13-20.
40. Subbarao, E. K., Park, E. J., Lawson, C. M., Chen, A. Y. & Murphy, B. R. (1995). Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine. Journal of Virology 69, 5969-5977.
41. Tulip, W. R., Varghese, J. N., Baker, A. T., van Donkelaar, A., Laver, W. G., Webster, R. G. & Colman, P. M. (1991). Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. Journal of Molecular Biology 221, 487-497.
42. Varghese, J. N., Laver, W. G. & Colman, P. M. (1983). Structure of the influenza virus glycoprotein antigen neuraminidase at 2-9 Å resolution. Nature 303, 35-40.
43. Varghese, J. N., McKimm-Breschkin, J. L., Caldwell, J. B., Kortt, A. A. & Colman, P. M. (1992). The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 14, 327-332.
44. von Itzstein, M., Wu, W. Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., Colman, P. M., Varghese, J. N., Ryan, D. M., Woods, J. M., Bethell, R. C., Hotham, V. J., Cameron, J. M. & Penn, C. R. (1993). Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423.
45. Webster, R. G., Laver, W. G., Air, G. M. & Schild, G. C. (1982). Molecular mechanisms of variation in influenza viruses. Nature 296, 115-121.
46. Webster, R. G., Bean, W. J., German, O. T., Chambers, T. M. & Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiological Reviews 56, 152-179.